Baltimore Pain Relief Center | |
4552 Edmondson Ave, Baltimore, MD 21229-1506 | |
(443) 725-4930 | |
(667) 212-2311 |
Full Name | Baltimore Pain Relief Center |
---|---|
Type | Facility |
Speciality | Pain Medicine - Interventional Pain Medicine |
Location | 4552 Edmondson Ave, Baltimore, Maryland |
Accepts Medicare Assignments | Does not participate in Medicare Program. The facility may not accept medicare assignment. |
Identifier | Type | State | Issuer |
---|---|---|---|
1306210521 | NPI | - | NPPES |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
111N00000X | Chiropractor | (* (Not Available)) | Secondary |
208VP0014X | Pain Medicine - Interventional Pain Medicine | (* (Not Available)) | Primary |
Mailing Address | Practice Location Address |
---|---|
Baltimore Pain Relief Center 5430 Campbell Blvd, White Marsh, MD 21162-5500 Ph: (443) 725-4930 | Baltimore Pain Relief Center 4552 Edmondson Ave, Baltimore, MD 21229-1506 Ph: (443) 725-4930 |
News Archive
Novasep, a leading supplier of services and technologies for the life sciences and chemical industries, and Celladon Corporation, a clinical-stage cardiovascular gene therapy company, today announce that they have signed a Development, Manufacturing and Supply Agreement pursuant to which, if supported by upcoming MYDICAR clinical data, Novasep would manufacture MYDICAR drug substance through 2018 with extension options through 2020.
Meetings begin this week to determine what benefits insurers must cover under the new health law. The resulting regulation will be just one of the ways in which the new health law will change the health care landscape.
As we grow older, our muscular function declines. A new study by researchers at Karolinska Institutet in Sweden shows how an unexpectedly high number of mutations in the stem cells of muscles impair cell regeneration.
When mice ate a diet of 25 percent extra sugar - the mouse equivalent of a healthy human diet plus three cans of soda daily - females died at twice the normal rate and males were a quarter less likely to hold territory and reproduce, according to a toxicity test developed at the University of Utah.
​Huma Q. Rana, MD of Harvard Medical School's Dana Farber Cancer Institute is the recipient of the 2014 Richard King Trainee Award. This award was instituted five years ago by the ACMG Foundation for Genetic and Genomic Medicine to encourage ABMG or genetic counseling trainees in their careers and to foster the publication of the highest quality research in ACMG's peer-reviewed journal, Genetics in Medicine (GIM).
› Verified 5 days ago